On February 1, 2016, an objection to the disclosure statement with respect to a plan of reorganization or liquidation was filed in the bankruptcy case of Health Diagnostic Laboratory, Inc. (a/k/a HDL, Inc.) and its affiliates.
The filing was assigned docket number 806 and is described on the court’s official docket as follows:
Objection of Creditors Committee to the Adequacy of the Debtors’ Disclosure Statement and (2) Motion to (A) Direct the Debtors to Alter the Plan or (B) Terminate the Exclusivity Periods in Which Only the Debtors May File a Plans and Solicit Acceptances Thereto (Re: related document(s) Motion to Approve filed by Health Diagnostic Laboratory, Inc.,  Amended/Modified Chapter 11 Plan filed by Health Diagnostic Laboratory, Inc.,  Amended Disclosure Statement filed by Health Diagnostic Laboratory, Inc.) filed by Douglas Paul Lobel of Cooley LLP on behalf of Official Committee of Unsecured Creditors. (Attachments: # (1) Exhibit(s) A # (2) Exhibit(s) B # (3) Exhibit(s) C # (4) Exhibit(s) D) (Lobel, Douglas)
Health Diagnostic Laboratory, Inc. (a/k/a HDL, Inc.) filed for bankruptcy protection, or had an involuntary bankruptcy petition filed against it, on June 7, 2015. The bankruptcy case is pending before the United States Bankruptcy Court for the Eastern District of Virginia . The case number for the lead bankruptcy case is 15-32919. The bankruptcy case is currently assigned to United States Bankruptcy Judge Kevin Huennekens. The law firm of Hunton & Williams LLP is acting as lead bankruptcy counsel to Health Diagnostic Laboratory, Inc. (a/k/a HDL, Inc.) in the bankruptcy case.